- Home
- ALM vs NVAX Comparison
ALM vs NVAX Comparison
Compare ALM & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALM | NVAX |
|---|---|---|
| Founded | N/A | 1987 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Other Metals and Minerals | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | ALM | NVAX |
|---|---|---|
| Price | $12.38 | $9.52 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 9 |
| Target Price | ★ $12.00 | $10.78 |
| AVG Volume (30 Days) | 3.6M | ★ 5.6M |
| Earning Date | 02-20-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 2.07 |
| Revenue | $21,591,798.00 | ★ $1,064,651,000.00 |
| Revenue This Year | $78.23 | $58.91 |
| Revenue Next Year | $228.77 | N/A |
| P/E Ratio | ★ N/A | $4.43 |
| Revenue Growth | 7.50 | ★ 20.27 |
| 52 Week Low | $1.03 | $5.01 |
| 52 Week High | $11.24 | $10.65 |
Technical Indicators
Market Signals| Indicator | ALM | NVAX |
|---|---|---|
| Relative Strength Index (RSI) | 77.87 | 67.32 |
| Support Level | $8.28 | $9.15 |
| Resistance Level | $9.30 | $10.13 |
| Average True Range (ATR) | 0.63 | 0.64 |
| MACD | 0.22 | 0.21 |
| Stochastic Oscillator | 85.11 | 80.20 |
Price Performance
Historical ComparisonAbout ALM Almonty Industries Inc.
Almonty Industries Inc is engaged in the mining, processing, and shipping of tungsten concentrate from its Los Santos tungsten mine located near Salamanca, Spain - the Los Santos Mine, the processing and shipping of tungsten concentrate from its Panasqueira tin and tungsten mine in Covilha, Castelo Branco, Portugal - the Panasqueira Mine, the evaluation of its Valtreixal tin and tungsten mine project located in Western Spain in the province of Zamora - the Valtreixal Mine, as well as the exploration and evaluation of its Sangdong tungsten mine project located in Gangwon Province, Republic of Korea - the Sangdong Mine.
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.